中证智能财讯嘉和美康（688246）2月27日晚间披露2025年业绩快报，公司实现营业收入4.08亿元，同比下降31.13%；归母净利润亏损2.53亿元，上年同期 亏损2.56亿元；扣非净利润亏损2.57亿元，上年同期亏损2.61亿元；基本每股收益-1.84元，加权平均净资产收益率为-17.69%。以最新收盘价计算，市净率 （LF）约2.43倍，市销率（TTM）约7.51倍。 以本次披露业绩快报数据计算，公司近年市盈率（TTM）图如下所示： 近年来市盈率变化情况 (倍) 800 ড্রি00 400 200 79o33 84.69 78:84 62.45 =2 93 54.7 0 30-24 -200 212.98 -400 2024-03-30 2023-09-30 ' 2023-12-30 ' 2024-06-30 3-06-30 24-12-30 34-09-30 2n- -○- 公司 -○- 行业均值 100 ହ 90 80 72 48 70 719 60 50 40 AC 30 20 15871 10 0 2023-12-30 | 2023-06-30 | 2024-06-30 | 4-03-30 ...

报告期内，受外部经济环境影响，地方财政给予公立医院进行医疗信息化建设的财政预算支持减少或延 迟到位，导致部分医院采购需求被压缩或延后；此外，随着医保支付改革的进一步深入，公立医院收入 减少且盈利空间被压缩，医院利用自有资金进行的软件采购变得更加谨慎。宏观环境及政策影响下的需 求侧骤然收紧导致客户采购意愿减弱，公司2025年收入大幅下滑。 格隆汇2月27日丨嘉和美康(688246.SH)公布2025年度业绩快报，公司2025年度实现营业收入4.08亿元， 较上年同期减少31.13%；实现归属于母公司所有者的净利润-2.53亿元，较上年同期亏损减少333.95万 元；实现归属于母公司所有者的扣除非经常性损益的净利润-2.57亿元，较上年同期亏损减少427.95万 元。 ...

资料显示，东华软件股份公司位于北京市海淀区紫金数码园3号楼16层，成立日期2001年1月20日，上市 日期2006年8月23日，公司主营业务涉及主要从事行业应用软件开发、计算机信息系统集成及相关服务 业务。主营业务收入构成为：系统集成收入68.15%，技术服务收入17.71%，软件收入14.09%，其他(补 充)0.05%。 2月27日，东华软件盘中上涨2.21%，截至10:44，报9.70元/股，成交3.69亿元，换手率1.32%，总市值 310.93亿元。 资金流向方面，主力资金净流入3258.25万元，特大单买入6388.42万元，占比17.30%，卖出3334.16万 元，占比9.03%；大单买入8353.32万元，占比22.62%，卖出8149.33万元，占比22.07%。 东华软件今年以来股价涨6.01%，近5个交易日跌0.41%，近20日跌2.90%，近60日跌8.32%。 东华软件所属申万行业为：计算机-IT服务Ⅱ-IT服务Ⅲ。所属概念板块包括：医疗信息化、智慧医疗、 国产软件、数字经济、华为算力等。 截至9月30日，东华软件股东户数31.52万，较上期减少2.68%；人均流通股9226股，较 ...

证券之星消息，截至2026年2月10日收盘，和仁科技(300550)报收于14.43元，上涨2.12%，换手率 2.1%，成交量5.5万手，成交额7888.62万元。 该股主要指标及行业内排名如下： 和仁科技2025年三季报显示，前三季度公司主营收入2.63亿元，同比下降0.33%；归母净利润1294.31万 元，同比上升1292.86%；扣非净利润1092.82万元，同比上升1124.98%；其中2025年第三季度，公司单 季度主营收入1.05亿元，同比上升0.7%；单季度归母净利润1646.31万元，同比上升7.87%；单季度扣非 净利润1534.14万元，同比上升2.87%；负债率22.73%，投资收益90.47万元，财务费用-264.64万元，毛 利率47.37%。和仁科技（300550）主营业务：公司是以医疗信息系统及数字化场景应用系统的研发销 售、实施集成、服务支持为主营业务的总体解决方案服务商。从流程、系统、数据的角度,公司为医疗 机构与医疗卫生管理及协作机构的数据采集、融合、处理、存储、传输、共享和应用提出基于自有核心 系统的整体解决方案。公司的主要业务可以分为医疗信息系统和数字化场景应用系统 ...

Core Viewpoint - JiuYuan YinHai's stock price has shown fluctuations with a year-to-date increase of 11.82%, while experiencing a recent decline over the past 20 days [1][2]. Group 1: Stock Performance - On February 10, JiuYuan YinHai's stock rose by 2.03%, reaching 20.06 CNY per share, with a trading volume of 1.82 billion CNY and a turnover rate of 2.26%, resulting in a total market capitalization of 81.89 billion CNY [1]. - The stock has seen a 0.45% increase over the last five trading days, a 9.72% decrease over the last 20 days, and a 6.48% increase over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, JiuYuan YinHai reported a revenue of 6.87 billion CNY, reflecting a year-on-year growth of 2.83%, and a net profit attributable to shareholders of 42.79 million CNY, which is a significant increase of 127.43% [2]. Group 3: Shareholder Information - As of January 9, 2025, the number of shareholders for JiuYuan YinHai was 51,200, a decrease of 7.78% from the previous period, with an average of 7,894 circulating shares per shareholder, an increase of 8.44% [2]. - The company has distributed a total of 4.72 billion CNY in dividends since its A-share listing, with 1.51 billion CNY distributed over the last three years [3]. Group 4: Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the third-largest circulating shareholder with 3.05 million shares, a decrease of 1.57 million shares from the previous period [3]. - Jin Ying Technology Innovation Stock A and Southern CSI 1000 ETF were also among the top shareholders, with Jin Ying being a new entrant holding 3 million shares [3].

Core Viewpoint - The development of internet hospital systems is a crucial aspect of modern healthcare information technology, aiming to achieve online, intelligent, and efficient medical services through the integration of various technologies [1][5]. Group 1: System Features - The system is designed to cover the entire patient care process, including online consultations, electronic prescriptions, remote consultations, health record management, drug delivery, and insurance settlement [1]. - The architecture follows principles of high availability, security, and scalability, allowing independent deployment of functional modules to enhance system stability and maintenance efficiency [3]. - Data security and privacy protection are core requirements, adhering to national health regulations and implementing multi-layer identity authentication, data encryption, and access control to prevent data breaches [3]. Group 2: Integration and Functionality - The system must integrate with traditional medical information systems like HIS, LIS, and PACS to ensure real-time synchronization and sharing of diagnostic data [3]. - It should support intelligent features such as smart triage, symptom self-check, and AI-assisted diagnosis to improve initial diagnosis accuracy and service response speed [3]. Group 3: Sustainable Development - Sustainable development of the internet hospital system requires policy support and inter-agency collaboration, including promoting interoperability with insurance systems and exploring reimbursement pathways for online consultations [4]. - Training and assessment of medical personnel for online practice are essential to standardize internet diagnosis and ensure quality and safety in medical services [4]. Group 4: Transformation of Healthcare Services - The development of internet hospital systems represents not only a technological innovation but also a profound transformation in healthcare service models, aiming to create an equitable, accessible, and high-quality smart healthcare service system [5].

Investment Rating - The report does not explicitly state an investment rating for the CDSS industry Core Insights - The Clinical Decision Support System (CDSS) is evolving from basic rule-based systems to intelligent, scenario-based solutions that integrate artificial intelligence and clinical knowledge, enhancing diagnostic accuracy and treatment standardization [5] - The market for CDSS in China is projected to grow from 540 million yuan in 2020 to 900 million yuan in 2024, with a compound annual growth rate (CAGR) of 13.4%, and is expected to reach 2.01 billion yuan by 2029, with a CAGR of 18.5% [8] - The penetration rate of CDSS in China is around 20%, significantly lower than the 74% in the United States, indicating substantial growth potential in the Chinese market [9] Market Background - CDSS is defined as an information tool that integrates medical knowledge and patient data to provide intelligent assistance to healthcare professionals, aimed at improving the quality and safety of clinical decisions [6] - The evolution of CDSS has gone through three main stages: rule-based systems, integration with hospital information systems, and the current phase that incorporates artificial intelligence and multi-source data [7] Market Status - The CDSS market in China is expected to see significant growth, particularly in specialized CDSS, which is projected to grow from 20 million yuan in 2020 to 190 million yuan in 2024, with a CAGR of 80.3% [8] - The demand for CDSS is primarily focused on enhancing medical quality and efficiency, with a high consensus across different economic regions on the need to optimize business processes and improve healthcare quality [10] Market Competition - The competitive landscape of the CDSS market in China is characterized by leading traditional IT vendors, emerging tech companies focusing on AI and big data, and cross-industry giants entering the market [15] - Key competitive dimensions include system performance and data advantages, technological innovation, and market positioning [12][13][14] Recommended Brands - The report highlights ten recommended brands in the CDSS market, including: 1. Weining Health 2. Chuangye Huikang 3. Neusoft Group 4. Yidu Tech 5. Senyi Intelligent 6. Huimei Technology 7. iFlytek 8. Baidu Lingyi Zhihui 9. Alibaba Health 10. Ping An Smart Healthcare [16][18][20][22][24][26] Development Trends - The CDSS industry is moving towards data and knowledge-driven upgrades, with a focus on utilizing machine learning to analyze clinical data and build dynamic medical knowledge graphs [28] - There is a trend towards diversified scenarios and solutions, with CDSS being tailored for specific diseases and integrated into new healthcare models [29] - Deployment and operational models are shifting towards cloud-based solutions, reducing costs and enabling rapid updates of algorithms and knowledge bases [30]

Core Viewpoint - Wanda Information is leveraging its wholly-owned subsidiary, Shanghai Fuga, to develop a next-generation hospital information system supported by a digital intelligence foundation, aimed at enhancing AI applications in healthcare and providing integrated smart services for patients throughout their medical journey [1] Group 1: Hospital Information System Development - The new hospital information system focuses on key aspects of the patient care process, including pre-diagnosis, diagnosis, and post-diagnosis services, utilizing electronic medical records as the core [1] - The system offers intelligent healthcare services such as medical record generation and quality control, and is designed for flexible configuration of workstations for doctors, nurses, and pharmacists through microservices [1] Group 2: Project Implementation and Impact - In 2025, the company will undertake an information technology project for a well-known tertiary hospital in Shanghai, which will include the implementation of a smart outpatient system and deep application of clinical and electronic medical record systems [1] - The project aims to enhance patient experiences in registration, consultation, and payment, thereby improving the quality, efficiency, and convenience of medical services at the hospital [1] Group 3: Medical Management Platform - The company completed a medical management platform project for a tertiary comprehensive hospital in Shanghai in 2025, addressing issues of disorganization, complex processes, and information silos in traditional medical management systems [1] - This platform aims to achieve systematic, process-oriented, integrated, and visualized medical management [1]

Core Viewpoint - The company has recently won a bid for a centralized procurement project in Guizhou Province, which aligns with the "Artificial Intelligence + Manufacturing" policy initiative, although the overall impact on the company's business is expected to be limited due to various influencing factors [1] Group 1: Company Developments - The recent project win in Guizhou is part of the company's expansion in the medical information sector, driven by supportive government policies [1] - The project is characterized as a single order, and its execution and benefits are subject to customer demand and implementation progress [1] - The company will continue to monitor and actively research market opportunities opened by relevant policies [1] Group 2: Industry Engagement - In the field of intelligent driving, the company primarily provides data labeling services to related enterprises and does not directly participate in the development of intelligent driving systems [1]

Core Insights - The project involves the construction of an information system and hardware environment for the Qianxinan Bouyei and Miao Autonomous Prefecture People's Hospital, aimed at meeting resource demands for the next five years and ensuring data integration with national, provincial, and municipal systems [1] Group 1: Project Scope - The project includes application system development covering various medical and administrative functions such as diagnosis, medical management, mobile services, nursing, pharmacy information management, medical technology, insurance services, and smart hospital services [1] - Supporting software will include domestic databases, middleware, and high-availability cluster software, along with evaluation support services, data governance services, interface services, and integration services [1] - Hardware components will consist of servers, hyper-converged systems, storage solutions, disaster recovery systems, data center switches, AI computing servers, and network security devices [1] Group 2: Integration Services - Hardware integration will provide standardized system integration services to ensure a secure, reliable, and high-performance hardware platform supporting business needs, including HIS, EMR, PACS, and LIS [3] - Software integration will involve the implementation, installation, debugging, and interface integration of various subsystems to create a cohesive operational platform [3] Group 3: System Development and Security - Advanced software systems will be developed, including electronic medical record systems, hospital information platforms, and smart management systems [4][15] - A comprehensive network security framework will be established, incorporating firewalls, intrusion detection, and data encryption [5][16] - Data backup and recovery mechanisms will be implemented to ensure data security and reliability [6][17] Group 4: Professional Staffing and System Development List - The project will require the allocation of specialized IT personnel and management staff to ensure effective system operation and management [18] - A detailed system development list includes various new systems such as multidisciplinary consultation management, electronic medical record quality control, and performance assessment systems, all requiring development and interoperability [18][19]